RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression

Documenti analoghi

• RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
  di: Meyer zu Horste, Gerd, et al.
  Pubblicazione: (2017)
• Pathological pericyte expansion and impaired endothelial cell-pericyte communication in endothelial Rbpj deficient brain arteriovenous malformation
  di: Samantha Selhorst, et al.
  Pubblicazione: (2022-09-01)
• SUMOylated non-canonical polycomb PRC1.6 complex as a prerequisite for recruitment of transcription factor RBPJ
  di: Małgorzata Sotomska, et al.
  Pubblicazione: (2021-07-01)
• Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
  di: Mengjie Rui, et al.
  Pubblicazione: (2022-04-01)
• An RBPJ-<i>Drosophila</i> Model Reveals Dependence of RBPJ Protein Stability on the Formation of Transcription–Regulator Complexes
  di: Bernd M. Gahr, et al.
  Pubblicazione: (2019-10-01)